John Robert Wilson Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Robert Wilson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Robert Wilson. John Robert Wilson is Director in Marker Therapeutics, Inc. ($TPIV) and Director in Allovir, Inc. ($ALVR).
Latest Insider Trading Transactions of John Robert Wilson
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | MRKR | Marker Therapeutic ... | Wilson John Robert | Director | Grant | A | 0.00 | 12,658 | 0 | 7,812,008 | 7.8 M to 7.8 M (+0.16 %) |
Mar 18 2021 | MRKR | Marker Therapeutic ... | Wilson John Robert | Director | Buy | P | 1.75 | 1,714,285 | 2,999,999 | 7,799,350 | 6.1 M to 7.8 M (+28.17 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 31.63 | 769 | 24,322 | 3,164,954 | 3.2 M to 3.2 M (-0.02 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 31.63 | 2,308 | 72,997 | 5,412,953 | 5.4 M to 5.4 M (-0.04 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 30.87 | 3,397 | 104,876 | 3,165,723 | 3.2 M to 3.2 M (-0.11 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 30.87 | 10,188 | 314,535 | 5,415,261 | 5.4 M to 5.4 M (-0.19 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 32.31 | 300 | 9,694 | 3,169,120 | 3.2 M to 3.2 M (-0.01 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 32.31 | 900 | 29,081 | 5,425,449 | 5.4 M to 5.4 M (-0.02 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 31.59 | 8,419 | 265,981 | 3,169,420 | 3.2 M to 3.2 M (-0.26 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 31.59 | 25,256 | 797,913 | 5,426,349 | 5.5 M to 5.4 M (-0.46 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 30.93 | 9,467 | 292,799 | 3,177,839 | 3.2 M to 3.2 M (-0.30 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 30.93 | 28,403 | 878,457 | 5,451,605 | 5.5 M to 5.5 M (-0.52 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 31.70 | 10,169 | 322,318 | 3,187,306 | 3.2 M to 3.2 M (-0.32 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 31.70 | 30,506 | 966,921 | 5,480,008 | 5.5 M to 5.5 M (-0.55 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 31.30 | 17,480 | 547,052 | 3,197,475 | 3.2 M to 3.2 M (-0.54 %) |
Mar 11 2021 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Sell | S | 31.30 | 52,440 | 1,641,157 | 5,510,514 | 5.6 M to 5.5 M (-0.94 %) |
Aug 06 2020 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Option Exercise | C | 0.00 | 3,499,001 | 0 | 0 | |
Aug 06 2020 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Option Exercise | C | 0.00 | 4,745,943 | 0 | 0 | |
Aug 06 2020 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Buy | C | 0.00 | 2,347,999 | 0 | 5,562,954 | 3.2 M to 5.6 M (+73.03 %) |
Aug 06 2020 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Buy | C | 0.00 | 3,184,758 | 0 | 3,214,955 | 30.2 K to 3.2 M (+10,546.60 %) |
Jul 31 2020 | ALVR | Allovir, Inc. | Wilson John Robert | Director | Option Exercise | A | 17.00 | 22,500 | 382,500 | 22,500 | |
May 13 2019 | MRKR | Marker Therapeutic ... | Wilson John Robert | Director | Grant | A | 0.00 | 7,260 | 0 | 6,068,043 | 6.1 M to 6.1 M (+0.12 %) |
Oct 19 2018 | TPIV | Marker Therapeutic ... | Wilson John Robert | Director | Option Exercise | A | 8.34 | 12,500 | 104,250 | 12,500 |
Page: 1